# Sorcero

> Sorcero is a Washington, DC company building medically-tuned AI for the people inside drug companies who translate science into evidence - medical affairs, safety, and scientific communications teams. Its platform ingests hundreds of fragmented data sources, from congress abstracts to adverse-event reports, and turns them into attributed, regulation-ready intelligence. It works with roughly a third of the world's top 30 pharma companies and raised a $42.5M Series B in November 2025.

- **Founded:** 2017
- **Headquarters:** Washington, District of Columbia, United States
- **Founders:** Dipanwita Das (CEO & Co-founder), Walter Bender (Chief Scientific Officer & Co-founder), Richard Graves (COO & President, Co-founder)
- **Team size:** ~72 employees
- **Products:** Sorcero Intelligence Platform, Sorcero Medical, Sorcero SciComms, Sorcero Safety, Sorcero Medtech
- **Notable:** $42.5M Series B in November 2025, bringing total funding to about $59M, Works with roughly a third of the top 30 global pharma companies, 2025 Google Cloud Partner of the Year for Business Applications in Healthcare & Life Sciences

## Products & services

- **Sorcero Intelligence Platform** — Core platform combining agentic AI trained for life sciences, a medically-enriched data pool, and an architecture built for regulatory and privacy requirements. Includes an Instant Insights Engine, scientific content generation, and data integration.
- **Sorcero Medical** — Turns fragmented global data and real-world evidence into unified, attributed, actionable intelligence for medical affairs teams.
- **Sorcero SciComms** — Generates manuscripts, plain language summaries, and value dossiers at accelerated speed for scientific communications teams.
- **Sorcero Safety** — Detects adverse-event reports from medical literature in minutes rather than months for pharmacovigilance teams.
- **Sorcero Medtech** — Extends the platform to medical device companies for evidence and insight workflows.
- **AI Agents for Life Sciences** — A team of specialized AI agents that validate, summarize, and prioritize real-time intelligence from field reports, advisory boards, CRM, surveys, literature, congress data and social media, with source attribution and hallucination controls.
- **Field Medical Excellence & Insights and Congress Intelligence** — Solutions that synthesize competitive shifts and scientific trends immediately after a medical congress and support field medical teams.

## Achievements

- $42.5M Series B in November 2025, bringing total funding to about $59M
- Works with roughly a third of the top 30 global pharma companies
- 2025 Google Cloud Partner of the Year for Business Applications in Healthcare & Life Sciences
- Named to Fortune / Inc. lists of America's most innovative companies
- Reports 96.1% clinical inclusion accuracy, above the FDA's 95% threshold
- Certified B Corporation and SOC 2 compliant

## Latest updates

- **2025-11** — Closed a $42.5M Series B led by NewSpring Growth to expand across medical affairs, safety, scientific communications and medtech.
- **2025-03** — Launched agentic AI framework - a team of specialized AI agents for life sciences - at the MAPS Americas Annual Meeting.
- **2025** — Won the 2025 Google Cloud Partner of the Year award for Healthcare & Life Sciences business applications.
- **2025** — Introduced Field Medical Excellence & Insights and Congress Intelligence solutions.

## Links

- Website: https://sorcero.com
- LinkedIn: https://www.linkedin.com/company/sorcero
- Twitter/X: https://twitter.com/SorceroCo
- Facebook: https://facebook.com/SorceroAI

---

Profile page: https://yespress.io/sorcero
Published by YesPress — https://yespress.io
Last updated: 2026-08-19